Basic and Clinical Studies of Pazufloxacin on Infectious Enteritis Research Group of T-3761 on Infectious Enteritis (Manager; Shoichiro IRIMAJIRI)
-
- SAGARA Hiroko
- Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital
-
- YOSHIKAWA Kouji
- Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital
-
- TOMIZAWA Isao
- Department of Infectious Diseases, Minamigaoka Branch, Sapporo City General Hospital
-
- TAKIZAWA Yoshihiko
- Department of Infectious Diseases, Minamigaoka Branch, Sapporo City General Hospital
-
- NITTA Yoshiro
- Department of Infectious Diseases, Tokyo Metropolitan Toshima General Hospital
-
- TSUNODA Takafumi
- Department of Infectious Diseases, Tokyo Metropolitan Toshima General Hospital
-
- FUKUDA Hiroyuki
- Department of Infectious Diseases, Tokyo Metropolitan Toshima General Hospital
-
- YAMAGUCHI Tsuyoshi
- Department of Infectious Diseases, Tokyo Metropolitan Komagome General Hospital
-
- MASUDA Gohta
- Department of Infectious Diseases, Tokyo Metropolitan Komagome General Hospital
-
- NEGISHI Masayoshi
- Department of Infectious Diseases, Tokyo Metropolitan Komagome General Hospital
-
- AJISAWA Atsushi
- Department of Infectious Diseases, Tokyo Metropolitan Komagome General Hospital
-
- MURATA Misako
- Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital
-
- OHNISHI Kenji
- Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital
-
- IRIMAJIRI Shoichiro
- Department of Internal Medicine, Kawasaki Municipal Hospital
-
- OBANA Mitsuo
- Department of Internal Medicine, Kawasaki Municipal Hospital
-
- MATSUMOTO Fumio
- Department of Internal Medicine, Kanagawa Prefectural Midwives Nurses Training Hospital
-
- IMAI Takero
- Department of Internal Medicine, Kanagawa Prefectural Midwives Nurses Training Hospital
-
- SAKURAI Iwao
- Department of Internal Medicine, Kanagawa Prefectural Midwives Nurses Training Hospital
-
- TAKAHASHI Takayuki
- Department of Internal Medicine, Kanagawa Prefectural Midwives Nurses Training Hospital
-
- MORI Masamiki
- Department of Communicable Diseases, Nagoya City Higashi General Hospital
-
- MIZUNO Yoshiki
- Department of Communicable Diseases, Nagoya City Higashi General Hospital
-
- KATOH Kohji
- Department of Communicable Diseases, Nagoya City Higashi General Hospital
-
- HOSODA Shiro
- Decond Department of Internal Medicine, Shiga Univresity of Medical Science
-
- BAMBA Tadao
- Decond Department of Internal Medicine, Shiga Univresity of Medical Science
-
- SASAKI Masaya
- Decond Department of Internal Medicine, Shiga Univresity of Medical Science
-
- YOSHIKAWA Kunio
- Department of Internal Medicine, Nagahama Red Cross Hospital
-
- HIROTANI Shuichi
- Department of Internal Medicine, Nagahama Red Cross Hospital
-
- OGASAWARA Takeshi
- Department of Internal Medicine, Otsu Municipal Hospital
-
- SAKUMOTO Hitoshi
- Department of Internal Medicine, Otsu Municipal Hospital
-
- KOMAI Yasunobu
- Department of Internal Medicine, Otsu Municipal Hospital
-
- OOKUBO Hideo
- Department of Communicable Diseases, Kyoto City Hospital
-
- KIM Young Ki
- Department of Communicable Diseases, Kyoto City Hospital
-
- NAKAJO Shinobu
- 大阪府済生会吹田病院内科
-
- OBATA Hirozumi
- 大阪府済生会吹田病院内科
-
- SAKAUE Yoshihiro
- Infectious Disease Center, Osaka City General Hospital
-
- YOSHIDA Hideki
- Infectious Disease Center, Osaka City General Hospital
-
- GOTO Tetsushi
- Infectious Disease Center, Osaka City General Hospital
-
- AISAKA Tadakazu
- Department of Internal Medicine, Hiroshima City Funairi Hospital
-
- MIKAMI Motoko
- Department of Internal Medicine, Hiroshima City Funairi Hospital
-
- KAGAWA Kazunori
- Department of Internal Medicine, Kure National Hospital
-
- IMAGAWA Yatsuka
- College of Enviromental Health, Azabu University
-
- FUKUYAMA Masafumi
- College of Enviromental Health, Azabu University
-
- MATSUBARA Yoshio
- Department of Internal Medicine, Kiyose Jogu Hospital
-
- SAITO Makoto
- Showa University
Bibliographic Information
- Other Title
-
- Pazufloxacin (PZFX) の感染性腸炎に対する基礎的・臨床的検討
- Pazufloxacin PZFX ノ カンセンセイ チョウ エン ニ タイス
Search this article
Abstract
A clinical study was carried out on pazufloxacin (PZFX) in 137 patients including shigellosis, Salmonella enteritis, enteropathogenic Esherichia coli enteritis and cholera, and carriers of these pathogens. Antibacterial activity of PZFX against clinical isolates, fecal concentration of PZFX and effects of PZFX on fecal microflora were also investigated.<BR>The overall clinical efficacy rate was 97.2%.<BR>The bacteriological efficacy rates were 98.2% against Shigella spp., 81.8% against Salmonella spp., 50% against Vibrio cholerae 01, and 100% against E. coli, V. parahaemolyticus, Aeronomas spp., Plesionomas shigelloides and V. cholerae non-01, respectively.<BR>Side effect (epigastralgia) was observed in 1 of 130 cases (0.8%).The rate of abnormal laboratory findings was 11.2%(11/98). These were mainly elevation of GOT and/or GPT and increased eosinophils.<BR>The clinical usefulness rate was 95.2%.<BR>The MIC90 values of PZFX against Shigella spp., Salmonella spp. and E. coli were 0.025, 0.025 and 0.025, μg/ml, respectively.<BR>The results of fecal drug concentration and the effects on fecal microflora in one patient were compatible with those obtained in healthy volunteers.
Journal
-
- Kansenshogaku Zasshi
-
Kansenshogaku Zasshi 70 (1), 60-72, 1996
The Japanese Association for Infectious Diseases
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001205046870784
-
- NII Article ID
- 130004112509
- 10008722327
-
- NII Book ID
- AN00047715
-
- ISSN
- 1884569X
- 03875911
-
- NDL BIB ID
- 3927724
-
- PubMed
- 8822054
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed